;){kind=link}
Mr. Pall
Address:
218 Fumin Road, Building 3, Jingkai District, 213025, Changzhou, Jiangsu, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2020
Business Range:
Health & Medicine
Management System Certification:
ISO 13485
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
Changzhou Biowin BioPharm Co., Ltd. is a high-tech biopharmaceutical enterprise specializing in rapid diagnostic reagents (POCT) founded by national experts and leading returnees. Founded in November 2011, the company is registered in the California Science and technology port, Qishuyan District, Changzhou City, close to Shanghai - Nanjing Expressway and Beijing - Shanghai railway, with convenient ...
Changzhou Biowin BioPharm Co., Ltd. is a high-tech biopharmaceutical enterprise specializing in rapid diagnostic reagents (POCT) founded by national experts and leading returnees. Founded in November 2011, the company is registered in the California Science and technology port, Qishuyan District, Changzhou City, close to Shanghai - Nanjing Expressway and Beijing - Shanghai railway, with convenient transportation. The company has 100000 level and 10000 level purification workshops, R & D laboratories
For colloidal gold, chemiluminescence and Molecular biological diagnosis, as well as Advanced production and testing equipment And experimental conditions. The company Has a R & D, production and marketing management team with national experts and returned doctors as the backbone to ensure product quality and service. The company′s main business direction is R & D, production and sales of rapid screening and testing products for major diseases, including Rapid screening and testing for Cardiovascular diseases, infectious diseases and Malignant tumors. The company has three Major technology platforms, namely, Colloidal gold quantitative detection technology, chemiluminescence quantitative detection technology and fluorescence quantitative PCR detection technology. The company has more than 30 rapid detection products, the rapid quantitative automatic detection technology of heart marker colloidal gold, including reagents (16 indicators) independently developed by the company, is a product with completely independent intellectual property rights in the domestic and foreign clinical test market. This series of products has the advantages of simple operation, fast detection, accurate and reliable results.
For colloidal gold, chemiluminescence and Molecular biological diagnosis, as well as Advanced production and testing equipment And experimental conditions. The company Has a R & D, production and marketing management team with national experts and returned doctors as the backbone to ensure product quality and service. The company′s main business direction is R & D, production and sales of rapid screening and testing products for major diseases, including Rapid screening and testing for Cardiovascular diseases, infectious diseases and Malignant tumors. The company has three Major technology platforms, namely, Colloidal gold quantitative detection technology, chemiluminescence quantitative detection technology and fluorescence quantitative PCR detection technology. The company has more than 30 rapid detection products, the rapid quantitative automatic detection technology of heart marker colloidal gold, including reagents (16 indicators) independently developed by the company, is a product with completely independent intellectual property rights in the domestic and foreign clinical test market. This series of products has the advantages of simple operation, fast detection, accurate and reliable results.
International Commercial Terms(Incoterms):
FOB
Terms of Payment:
LC, T/T, PayPal
Number of Foreign Trading Staff:
4~10 People
Export Year:
2020-03-01
Export Percentage:
21%~30%
Main Markets:
South America, Eastern Europe, Southeast Asia, Eastern Asia
Nearest Port:
shanghai
Import & Export Mode:
Exportation via agency
Factory Address:
No.218 Fumin Road, Jingkai District, Changzhou, Jiangsu, China
R&D Capacity:
Own Brand(Biowin)
No. of R&D Staff:
11-20 People
No. of Production Lines:
4
Annual Output Value:
US$10 Million - US$50 Million